Taken together with its potent pleiotropic biological activities, including anti-inflammatory and anti-fibrotic effects26–29, deregulated adiponectin signaling is likely to have a role in SSc pathogenesis. This evidence concerns the gene ADIPOQ and systemic sclerosis.